Publications

Cicka, D. & Sukhatme, VP. (2021). Available drugs and supplements for rapid deployment for treatment of COVID-19. Journal of Molecular Cell Biology, Advance Online Publication.

Sukhatme, VP & Sukhatme, VV (2021, February 9). A Call to Action: Immediate Deployment of Select Repurposed Drugs for COVID-19 Outpatient Treatment. Health Affairs.

Sukhatme, VP & Sukhatme, VV (2021, May 11). Existing Affordable Drugs Could Rapidly Reduce Covid-19 Cases and Deaths in India. The Times of India.

Sukhatme, VP, Reiersen, AM, Vayttaden, SJ & Sukhatme, VV. (2021). Fluvoxamine: A Review of Its Mechanism of Action and Its Role in COVID-19. Frontiers in Pharmacology, Advance Online Publication.

William A. Stokes, Madhusmita Behera, Renjian Jiang, David A. Gutman, Zhonglu Huang, Abigail Burns, Nikhil T. Sebastian ,Sukhatme , Michael C. Lowe, Suresh S. Ramalingam , Vikas P. Sukhatme , Drew Moghanaki (2022). Impact of concomitant fibrates on immunotherapy outcomes for advanced non-small cell lung cancer

Sukhatme, VP & Sukhatme, VV (2023, Nov 7). Rapid Development of New and Affordable Medical Treatments. Published in Harvard Advanced Leadership Initiative Social Impact Review